A Rare Case of Polymyositis and Systemic Sclerosis Overlap Syndrome: Diagnosis and Treatment

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Apr 24

PMID 37090317

Authors

Mohammad K Uddin

Roopeessh Vempati

Sravani Bhavanam

Praver Chandan C Parven

Chinmay Khotele

Raja H Chitturi

Smaran Kasireddy

Mahak Bhandari

Sweta Sahu

Affiliations

Soon will be listed here.

Abstract

Diffuse scleroderma is a kind of scleroderma in which the immune system malfunctions, leading to excessive production of collagen in the skin and a variety of organ abnormalities. Based on previously recognized criteria, overlap syndrome is a disorder in which two or more medical illnesses are documented in a single patient. These syndromes are significantly more prevalent in illnesses with mixed connective tissue. In this case report, we present a patient with overlapping systemic sclerosis and polymyositis symptoms. The treatment and diagnosis of this extremely uncommon condition are discussed in further detail.

Citing Articles

Calcinosis Cutis in Juvenile Systemic Sclerosis.

Balaji D, Mohanasundaram K, Gopalakrishnan K Cureus. 2024; 16(5):e59729.

PMID: 38841009 PMC: 11151205. DOI: 10.7759/cureus.59729.

References

Gordon S, Hughes J, Nee R, Stitt R, Bailey W, Little D . Systemic sclerosis medications and risk of scleroderma renal crisis. BMC Nephrol. 2019; 20(1):279. PMC: 6659266. DOI: 10.1186/s12882-019-1467-y. View

Pope J, Denton C, Johnson S, Fernandez-Codina A, Hudson M, Nevskaya T . State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol. 2023; 19(4):212-226. PMC: 9970138. DOI: 10.1038/s41584-023-00909-5. View

Danieli M, Fraticelli P, Salvi A, Gabrielli A, Danieli G . Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol. 1998; 17(3):195-201. DOI: 10.1007/BF01451046. View

Steen V . Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005; 35(1):35-42. DOI: 10.1016/j.semarthrit.2005.03.005. View

Ghosh S, Sinha S, Thomas T, Sachdev H, Kurpad A . Revisiting Dietary Iron Requirement and Deficiency in Indian Women: Implications for Food Iron Fortification and Supplementation. J Nutr. 2019; 149(3):366-371. PMC: 6398383. DOI: 10.1093/jn/nxy283. View

Steen V, Ziegler G, Rodnan G, Medsger Jr T . Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984; 27(2):125-31. DOI: 10.1002/art.1780270202. View

Koenig M, Dieude M, Senecal J . Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Autoimmun Rev. 2008; 7(8):588-93. DOI: 10.1016/j.autrev.2008.06.010. View

Fallahi P, Ruffilli I, Giuggioli D, Colaci M, Ferrari S, Antonelli A . Associations between Systemic Sclerosis and Thyroid Diseases. Front Endocrinol (Lausanne). 2017; 8:266. PMC: 5632355. DOI: 10.3389/fendo.2017.00266. View

Ranque B, Authier F, Berezne A, Guillevin L, Mouthon L . Systemic sclerosis-associated myopathy. Ann N Y Acad Sci. 2007; 1108:268-82. DOI: 10.1196/annals.1422.029. View

10.

Caetano J, Nihtyanova S, Harvey J, Denton C, Ong V . Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis. Rheumatol Adv Pract. 2019; 2(1):rky002. PMC: 6649979. DOI: 10.1093/rap/rky002. View

11.

Denton C, Hughes M, Gak N, Vila J, Buch M, Chakravarty K . BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology (Oxford). 2016; 55(10):1906-10. DOI: 10.1093/rheumatology/kew224. View

12.

van den Hoogen F, Khanna D, Fransen J, Johnson S, Baron M, Tyndall A . 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013; 72(11):1747-55. DOI: 10.1136/annrheumdis-2013-204424. View

13.

Katsumata K . A case of systemic sclerosis complicated by autoimmune hemolytic anemia. Mod Rheumatol. 2006; 16(3):191-5. DOI: 10.1007/s10165-006-0480-8. View

14.

Follansbee W, Zerbe T, Medsger Jr T . Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J. 1993; 125(1):194-203. DOI: 10.1016/0002-8703(93)90075-k. View

15.

Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K . Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol. 2004; 24(2):99-102. DOI: 10.1007/s10067-004-0975-7. View

16.

Li Z, Xu D, Jiang X, Li T, Su Y, Mu R . Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study. J Clin Med. 2022; 11(17). PMC: 9456668. DOI: 10.3390/jcm11175013. View

17.

Nihtyanova S, Sari A, Harvey J, Leslie A, Derrett-Smith E, Fonseca C . Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis. Arthritis Rheumatol. 2019; 72(3):465-476. DOI: 10.1002/art.41153. View

18.

Morales-Cardenas A, Perez-Madrid C, Arias L, Ojeda P, Mahecha M, Rojas-Villarraga A . Pulmonary involvement in systemic sclerosis. Autoimmun Rev. 2016; 15(11):1094-1108. DOI: 10.1016/j.autrev.2016.07.025. View

19.

Bhansing K, Lammens M, Knaapen H, van Riel P, van Engelen B, Vonk M . Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology. Arthritis Res Ther. 2014; 16(3):R111. PMC: 4060195. DOI: 10.1186/ar4562. View

20.

Capriello S, Ferrari S, Gatto I, Santaguida M, Fallahi P, Antonelli A . Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis. Front Immunol. 2022; 13:921260. PMC: 9296862. DOI: 10.3389/fimmu.2022.921260. View